olmesartan has been researched along with Cardiomegaly in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, K; Kamiya, M; Mizuno, K; Murai, K; Noma, S; Sato, N; Shimizu, W; Shirakabe, A | 1 |
| Bai, HY; Chisaka, T; Horiuchi, M; Iwanami, J; Kanno, H; Min, LJ; Mogi, M; Nakaoka, H; Ohshima, K; Tsukuda, K; Wang, XL | 1 |
| Cui, X; Fu, M; Ge, J; Hu, K; Liao, J; Sun, A; Xu, J; Zhou, J; Zhu, H; Zou, Y | 1 |
| Bin, J; Cao, S; Chen, C; Huang, X; Kitakaze, M; Li, G; Li, X; Liao, Y; Shen, L; Xu, D; Xuan, W; Zhang, J | 1 |
| Hayashi, M; Horimai, C; Yamashita, M; Yoshida, T | 1 |
| Ichikawa, H; Kimura, Y; Kinjo, T; Narita, I; Nishizaki, K; Okumura, K; Osanai, T; Tanaka, M; Tanno, T; Tomita, H | 1 |
| Fukamizu, A; Honjo, K; Inaba, S; Ishida, J; Nakamura, S; Sakairi, A; Sugiyama, F; Yagami, K | 1 |
| Fukuda, I; Fukui, K; Minakawa, M; Suzuki, Y | 1 |
| Adachi, Y; Harada, M; Horiuchi, M; Kinoshita, H; Kishimoto, I; Kuwahara, K; Li, Y; Murray, M; Nakanishi, M; Nakao, K; Rong, X; Saito, Y | 1 |
| Bai, Y; Dejima, T; Hirawa, N; Horiuchi, M; Ichihara, N; Ishigami, T; Kobayashi, Y; Maeda, A; Masuda, S; Matsuda, M; Minamisawa, S; Mogi, M; Shigenaga, A; Tamura, K; Tanaka, Y; Toya, Y; Umemura, S; Wakui, H; Yabana, M | 1 |
| Ge, J; Gong, H; Komuro, I; Li, L; Lin, L; Wu, J; Zhou, N; Zou, Y | 1 |
| Hatipoglu, FO; Hirohata, S; Iwamoto, M; Kusachi, S; Miyoshi, T; Ninomiya, Y; Ogawa, H; Ohtsuki, T; Shinohata, R; Yamamoto, K | 1 |
| Fujita, M; Hirata, A; Hori, M; Kitakaze, M; Liao, Y; Minamino, T; Nagamachi, Y; Nakatani, T; Ogawa, S; Okada, K; Ozawa, K; Takashima, S; Tomoike, H; Tsukamoto, O; Tsukamoto, Y; Yutani, C | 1 |
| Averill, DB; Brosnihan, KB; Ferrario, CM; Schiffrin, EL; Smith, RD; Yokoyama, H | 1 |
| Berry, NC; Inagaki, K; Koyanagi, T; Mochly-Rosen, D; Sun, L | 1 |
15 other study(ies) available for olmesartan and Cardiomegaly
| Article | Year |
|---|---|
Effect of Gonadectomy and Angiotensin II Receptor Blockade in a Mouse Model of Isoproterenol-induced Cardiac Diastolic Dysfunction.
Topics: Angiotensin Receptor Antagonists; Animals; Cardiomegaly; Castration; Diastole; Disease Models, Animal; Echocardiography; Female; Heart Failure; Heart Ventricles; Humans; Imidazoles; Isoproterenol; Male; Mice, Inbred Strains; Stroke Volume; Tetrazoles | 2021 |
Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Cardiomegaly; Epithelial Sodium Channels; Imidazoles; Male; Mice; Mice, Inbred C57BL; Oxadiazoles; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Sodium; Tetrazoles | 2014 |
Olmesartan attenuates cardiac hypertrophy and improves cardiac diastolic function in spontaneously hypertensive rats through inhibition of calcineurin pathway.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Calcineurin; Cardiomegaly; Diastole; Down-Regulation; Fibrosis; Heart Rate; Hypertension; Imidazoles; Male; NFATC Transcription Factors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 2014 |
Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation.
Topics: Adenoviridae; Angiotensin II; Animals; Animals, Newborn; Aorta; Atrial Natriuretic Factor; Calcineurin; Calpain; Cardiomegaly; Constriction, Pathologic; Cyclosporine; Gene Expression Regulation; Genetic Vectors; Glycoproteins; Imidazoles; Mice; Muscle Proteins; Myocytes, Cardiac; Myosin Heavy Chains; Nuclear Proteins; Primary Cell Culture; Protein Transport; Rats; Repressor Proteins; RNA, Small Interfering; Signal Transduction; Tetrazoles | 2014 |
Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Cardiomegaly; Cell Line; Gene Expression; Gene Expression Regulation; Histone Deacetylase Inhibitors; Hydroxamic Acids; Imidazoles; Isoproterenol; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, C-Type; Nuclear Proteins; Protein Precursors; Tetrazoles; Trans-Activators | 2014 |
Olmesartan Inhibits Cardiac Hypertrophy in Mice Overexpressing Renin Independently of Blood Pressure: Its Beneficial Effects on ACE2/Ang(1-7)/Mas Axis and NADPH Oxidase Expression.
Topics: Animals; Blood Pressure; Cardiomegaly; Fibrosis; Gene Expression; Hydralazine; Imidazoles; Male; Mice; Myocytes, Cardiac; NADPH Oxidases; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Signal Transduction; Tetrazoles | 2016 |
Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Female; Fibrosis; Hypertension, Pregnancy-Induced; Imidazoles; Male; Mice; Mice, Transgenic; Myocardium; Pregnancy; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrazoles; Ventricular Remodeling | 2008 |
Olmesartan improves left ventricular function in pressure-overload hypertrophied rat heart by blocking angiotensin II receptor with synergic effects of upregulation of angiotensin converting enzyme 2.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Disease Models, Animal; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Heart; Humans; Imidazoles; Male; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Up-Regulation; Ventricular Function, Left | 2009 |
Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart.
Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Body Weight; Cardiomegaly; Collagen; Heart; Imidazoles; Immunoblotting; Male; Mice; Mice, Knockout; Myocardium; Organ Size; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Atrial Natriuretic Factor; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Vasoconstrictor Agents | 2009 |
Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Body Weight; Cardiomegaly; Genotype; Heart Rate; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mitogen-Activated Protein Kinase Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrazoles | 2010 |
Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Echocardiography; Gene Expression; Hemodynamics; Imidazoles; Losartan; Male; Mice; Myocardium; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2010 |
Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cardiomegaly; Connective Tissue Growth Factor; Echocardiography; Enzyme-Linked Immunosorbent Assay; Fibrosis; Heart; Hydralazine; Imidazoles; Immunohistochemistry; Male; Myocardium; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Transforming Growth Factor beta1 | 2010 |
Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Valve Stenosis; Apoptosis; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Progression; Endoplasmic Reticulum; Gene Expression Regulation; Heart Failure; Humans; Imidazoles; Ligation; Male; Mice; Mice, Inbred C57BL; Molecular Chaperones; Myocytes, Cardiac; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Inbred WKY; RNA, Messenger; Signal Transduction; Stress, Physiological; Tetrazoles; Thapsigargin; Tunicamycin | 2004 |
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiomegaly; Collagen; Disease Progression; Endothelium, Vascular; Heart Rate; Hypertension; Imidazoles; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles; Vascular Diseases; Vascular Resistance | 2005 |
Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Drug Therapy, Combination; Enzyme Inhibitors; Heart Failure; Hypertension; Imidazoles; Male; Protein Kinase C-epsilon; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Tetrazoles | 2008 |